Patents by Inventor Luc Clauzel

Luc Clauzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
    Publication number: 20070066682
    Abstract: This invention provides compounds of formula (IIA) and pharmaceutical compositions thereof, where M, a, b, and R1-R5 are as defined herein, for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes. Pharmaceutical compositions comprising the compounds of formula (IIA) are also disclosed.
    Type: Application
    Filed: July 3, 2006
    Publication date: March 22, 2007
    Inventors: Miriam Exposito, Luc Clauzel, Anna Martin, Silvia Vicente, Xavier Yinbert, Antonio Olarte, Manuel Prieto, Fernando Palomera, Francesc Font, Alec Mian
  • Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof
    Publication number: 20070066646
    Abstract: This invention is directed to inhibitors of copper-containing amine oxidases (E.C. 1.4.3.6) including semicarbazide-sensitive amine oxidase (SSAO; also known as vascular adhesion protein-1, VAP-1), and their therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer.
    Type: Application
    Filed: August 2, 2006
    Publication date: March 22, 2007
    Applicant: GENMEDICA THERAPEUTICS SL
    Inventors: Luc Clauzel, Francesc Font, Silvia Vicente, Miriam Royo Exposito, Fernando Palomera, Antonio Olarte
  • Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia
    Publication number: 20060165814
    Abstract: Combinations comprising vanadium (IV)/(V) compounds and pharmaceutically acceptable amines are provided. Combinations thereof are provided for the treatment or prevention of dyslipidemia, diabetes, obesity, metabolic syndrome or cardiovascular diseases.
    Type: Application
    Filed: December 16, 2005
    Publication date: July 27, 2006
    Applicant: Genmedica Therapeutics SL
    Inventors: Alec Mian, Antonio Olarte, Luc Clauzel